I start by wishing everybody a very happy 2020!
The last two years have been very eventful for me.
In 2018, my prostate cancer came back quite aggressively. After my Cyberknife and a short ADT for my extra-capsular recurrence in 2016/17, my PSA started rising quite rapidly with a PSADT of less than two months. A PSA of 0.2 in April 2018 rose to 4.48 by the middle of November 2018. A 18F-DCFPyL PET/CT scan at NIH in October found many abdominal and pelvic lymph nodes light up very strongly. A biopsy of a perirectal lymph node confirmed metastatic prostate cancer.
In 2019, I was on Lupron + Casodex and my PSA dropped sharply from 4.48 to 0.06 in November. Currently, I am on Lupron + Casodex vacation.
In 2020, I expect my PSA to remain low until my Testosterone rises from castrate level. If the change follows the same pattern as 9 month of ADT I had before and after Cyberknife, it could take up to nine months. Unexpected things can happen and I may find myself with castrate resistant cancer.
The brachytherapy I had in 2011 got rid of cancer from prostate gland as confirmed by a biopsy in 2016 and the above mentions PET/CT scan. The recurrent mass outside my prostate and attached to it has completely disappeared. So, why I have metastatic prostate cancer? To end up with metastatic prostate cancer from an initial diagnosis of Gleason 3 + 3 low volume cancer is very surprising for me.
Let us hope 2020 will not disappoint me.